| Accession Number: | 0001209191-21-052787 |
| Date: | 2021-08-19 |
| Issuer: | PMV PHARMACEUTICALS, INC. (PMVP) |
| Original Submission Date: |
MACK DAVID HENRY
C/O PMV PHARMACEUTICALS, INC.
8 CLARKE DRIVE, SUITE 3
CRANBURY, NJ 08512
| Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
|---|---|---|---|---|---|---|---|---|---|
| COMMON STOCK | 2021-08-19 | M | 5,500 | a | $0.53 | 17,970 | direct | ||
| COMMON STOCK | 2021-08-19 | 0 | $0.00 | 227,915 | indirect | f1 | |||
| COMMON STOCK | 2021-08-19 | 0 | $0.00 | 56,978 | indirect | f2 |
| Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| STOCK OPTION (RIGHT TO BUY) | 0.53 | 2021-08-19 | deemed execution date | M | 5,500 (d) | 2025-05-11 | common stock 5,500 | $0.53 | 441,574 | direct |
| ID | footnote |
|---|---|
| f1 | the shares are held of record by the mack-mulligan revocable trust, for which the reporting person serves as co-trustee. |
| f2 | the shares are held of record by the mack/mulligan 2020 irrevocable descendants' trust, for which the reporting person serves as co-trustee. |
| f3 | the shares subject to the option are fully vested and immediately exercisable. |
